clinical trial · NCT06545136
Long Term Follow-up Study of Type-1 Gaucher Subjects Post FLT201 Dose (GALILEO-2)
Gaucher Disease, Type 1FLT201
brief summary
This is a multicenter, long-term, follow-up trial of participants with Gaucher disease type 1 who received FLT201 treatment in a preceding clinical trial. Participants will be followed for 5 years post-treatment.
started
May 13, 2024
primary completion
May 1, 2029
completion
May 1, 2029
last updated
Nov 4, 2025
official title
A Multicenter, Long-term, Follow-up Study to Investigate the Safety and Durability of Response Following Dosing of an Adeno-associated Viral Vector (FLT201) in Subjects With Gaucher Disease (GALILEO-2)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol